Corvus Pharmaceuticals (CRVS) EPS (Basic) Growth (1y) (2016 - 2026)
Corvus Pharmaceuticals (CRVS) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | -166.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.70% |
| Sep 30, 2025 | 79.97% |
| Jun 30, 2025 | -58.53% |
| Mar 31, 2025 | 280.16% |
| Sep 30, 2024 | -465.26% |
| Jun 30, 2024 | 43.83% |
| Mar 31, 2024 | 8.23% |
| Dec 31, 2023 | 3.84% |
| Sep 30, 2023 | 61.51% |
| Jun 30, 2023 | 30.37% |
| Mar 31, 2023 | 21.61% |
| Dec 31, 2022 | 28.08% |
| Sep 30, 2022 | -26.40% |
| Jun 30, 2022 | 43.03% |
| Mar 31, 2022 | 51.16% |
| Dec 31, 2021 | 50.38% |
| Sep 30, 2021 | 37.51% |
| Jun 30, 2021 | 25.82% |
| Mar 31, 2021 | 23.87% |
| Dec 31, 2020 | 10.56% |